Establishing a post-op treatment protocol within your practice is the first step, but effectively communicating it with your patients ultimately determines its success. Our experts explain how they work with their patients to ensure they understand the steps involved and how to execute them properly.
Cataract Surgery • Prolensa
Please see Indication and Important Safety Information below
Download and share these resources with your practice and patients.
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Click here for full prescribing information on PROLENSA®
PROLENSA is a trademark of Bausch & Lomb Incorporated or its affiliates. Any other products/brand names are trademarks of the respective owners.